These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 19926732

  • 1. Effects of formoterol and salmeterol on cytokine release from monocyte-derived macrophages.
    Donnelly LE, Tudhope SJ, Fenwick PS, Barnes PJ.
    Eur Respir J; 2010 Jul; 36(1):178-86. PubMed ID: 19926732
    [Abstract] [Full Text] [Related]

  • 2. Anti-inflammatory activity of beta2-agonists in primary lung epithelial cells is independent of glucocorticoid receptor.
    Lovén J, Svitacheva N, Jerre A, Miller-Larsson A, Korn SH.
    Eur Respir J; 2007 Nov; 30(5):848-56. PubMed ID: 17596271
    [Abstract] [Full Text] [Related]

  • 3. Budesonide prevents cytokine-induced decrease of the relaxant responses to formoterol and terbutaline, but not to salmeterol, in mouse trachea.
    Adner M, Larsson B, Säfholm J, Naya I, Miller-Larsson A.
    J Pharmacol Exp Ther; 2010 Apr; 333(1):273-80. PubMed ID: 20061444
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of two long-acting beta2-agonists on cytokine secretion by human airway epithelial cells.
    Chiu JC, Hsu JY, Fu LS, Chu JJ, Chi CS.
    J Microbiol Immunol Infect; 2007 Oct; 40(5):388-94. PubMed ID: 17932597
    [Abstract] [Full Text] [Related]

  • 5. Effects of formoterol and salmeterol on the production of Th1- and Th2-related chemokines by monocytes and bronchial epithelial cells.
    Hung CH, Chu YT, Hua YM, Hsu SH, Lin CS, Chang HC, Lee MS, Jong YJ.
    Eur Respir J; 2008 Jun; 31(6):1313-21. PubMed ID: 18256057
    [Abstract] [Full Text] [Related]

  • 6. Albuterol does not antagonize the inhibitory effect of dexamethasone on monocyte cytokine release.
    Seldon PM, Stevens DA, Adcock IM, O'Connor BJ, Barnes PJ, Giembycz MA.
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):803-9. PubMed ID: 9517594
    [Abstract] [Full Text] [Related]

  • 7. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma.
    Wilson SJ, Wallin A, Della-Cioppa G, Sandström T, Holgate ST.
    Am J Respir Crit Care Med; 2001 Sep 15; 164(6):1047-52. PubMed ID: 11587995
    [Abstract] [Full Text] [Related]

  • 8. Differences in the pharmacodynamics of budesonide/formoterol and salmeterol/fluticasone reflect differences in their therapeutic usefulness in asthma.
    Lindmark B.
    Ther Adv Respir Dis; 2008 Oct 15; 2(5):279-99. PubMed ID: 19124378
    [Abstract] [Full Text] [Related]

  • 9. Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells.
    Tannheimer SL, Sorensen EA, Haran AC, Mansfield CN, Wright CD, Salmon M.
    Pulm Pharmacol Ther; 2012 Apr 15; 25(2):178-84. PubMed ID: 22306235
    [Abstract] [Full Text] [Related]

  • 10. Long-acting β2 agonists and corticosteroids restore the reduction of histone deacetylase activity and inhibit H2O2-induced mediator release from alveolar macrophages.
    Perng DW, Su KC, Chou KT, Wu YC, Chen CS, Hsiao YH, Tseng CM, Chen YH, Hsueh TY, Lee YC.
    Pulm Pharmacol Ther; 2012 Aug 15; 25(4):312-8. PubMed ID: 22546485
    [Abstract] [Full Text] [Related]

  • 11. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
    Cooper PR, Kurten RC, Zhang J, Nicholls DJ, Dainty IA, Panettieri RA.
    Br J Pharmacol; 2011 Jun 15; 163(3):521-32. PubMed ID: 21306583
    [Abstract] [Full Text] [Related]

  • 12. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
    Scola AM, Chong LK, Suvarna SK, Chess-Williams R, Peachell PT.
    Br J Pharmacol; 2004 Jan 15; 141(1):163-71. PubMed ID: 14662724
    [Abstract] [Full Text] [Related]

  • 13. Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells.
    Strandberg K, Palmberg L, Larsson K.
    J Asthma; 2008 Apr 15; 45(3):201-3. PubMed ID: 18415826
    [Abstract] [Full Text] [Related]

  • 14. The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.
    Linden M.
    Br J Pharmacol; 1992 Sep 15; 107(1):156-60. PubMed ID: 1358381
    [Abstract] [Full Text] [Related]

  • 15. Budesonide and formoterol inhibit ICAM-1 and VCAM-1 expression of human lung fibroblasts.
    Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF.
    Eur Respir J; 2000 Jan 15; 15(1):68-74. PubMed ID: 10678623
    [Abstract] [Full Text] [Related]

  • 16. Beta2-agonists potentiate corticosteroid-induced neutrophil survival.
    Perttunen H, Moilanen E, Zhang X, Barnes PJ, Kankaanranta H.
    COPD; 2008 Jun 15; 5(3):163-9. PubMed ID: 18568840
    [Abstract] [Full Text] [Related]

  • 17. Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells.
    Strandberg K, Palmberg L, Larsson K.
    Respir Med; 2007 Jun 15; 101(6):1132-9. PubMed ID: 17229563
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of formoterol and budesonide on chemokine release, chemokine receptor expression and chemotaxis in human neutrophils.
    Strandberg K, Blidberg K, Sahlander K, Palmberg L, Larsson K.
    Pulm Pharmacol Ther; 2010 Aug 15; 23(4):316-23. PubMed ID: 20307681
    [Abstract] [Full Text] [Related]

  • 20. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
    Spoelstra FM, Postma DS, Hovenga H, Noordhoek JA, Kauffman HF.
    Thorax; 2002 Mar 15; 57(3):237-41. PubMed ID: 11867828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.